本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Caris Life Sciences, Inc.

28.54
+0.04000.14%
成交量:156.58萬
成交額:4,442.63萬
市值:80.52億
市盈率:76.72
高:29.09
開:28.16
低:27.91
收:28.50
52周最高:34.54
52周最低:14.19
股本:2.82億
流通股本:1.16億
量比:0.81
換手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):0.3720
每股收益(LYR):-3.2200
淨資產收益率:20.13%
總資產收益率:8.77%
市淨率:13.61
市盈率(LYR):-8.86

資料載入中...

2020/07/29

重要事件披露

8-K - Current report
2020/07/08

重要事件披露

8-K - Current report
2020/06/15

重要事件披露

8-K - Current report
2020/05/05

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/04/29

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/06

重要事件披露

8-K/A [Amend] - Current report
2020/03/05

重要事件披露

Current report, items 2.02 and 9.01
2020/03/05

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/29

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/22

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/01

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/10/29

重要事件披露

Current report, items 2.02 and 9.01